The primary antibodies in this study were as follows: goat anti-ephrin-B1 (R&D Systems; AF473); mouse anti-α sarcomeric actinin (Sigma-Aldrich, Cat# A7732, RRID:AB_2221571 or Abcam, Cat# ab68167, RRID:AB_11157538); mouse anti-connexin 43 (Millipore; MAB3067); rabbit anti-N-cadherin (Epitomics; 2019-1); rabbit anti-desmoplakin 1/2 (ARP American Research Products, Cat# 03-61003, RRID:AB_1541118); rabbit anti-claudin-5 (Acris Antibodies, Cat# DP157, RRID:AB_978124); mouse anti-GAPDH (Abcam, Cat# ab9484, RRID:AB_307274), mouse anti-Ryanodine Receptor (Abcam, Cat# ab2868, RRID:AB_2183051), and mouse anti-caveolin-3 (BD Biosciences, Cat# 610420, RRID:AB_397800). The secondary fluorescent antibodies used in this study were as follows: donkey anti-goat Alexa Fluor488 (Molecular Probes, Cat# A-11055, RRID:AB_2534102); donkey anti-mouse Alexa Fluor488 (Cat# A-21202, RRID:AB_141607), goat anti-rabbit Oregon-Green488 (Cat# 011038), donkey anti-goat Alexa Fluor568 (Cat# A-11057, RRID:AB_2534104), and donkey anti-rat Alexa Fluor568 (Cat# A-11007, RRID:AB_10561522), all obtained from Thermo Fisher Scientific. Cell nuclei were stained with 4′,6-Diamidino-2-phenylindole dihydrochloride-DAPI (Sigma-Aldrich, Cat# 32670) or TO-PRO–3 Iodide (642/661) (Invitrogen; Cat# T3605).
Free full text: Click here